Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Clinical trial NCT00920140 · COMPLETED
Trial details
- NCT number
- NCT00920140
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-04-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.